C4 Therapeutics (CCCC) Accounts Payables (2019 - 2026)
C4 Therapeutics (CCCC) posted quarterly Accounts Payables of $773000.0 for Q1 2026, up 13.18% year-over-year from $683000.0 in Q1 2025, and down 9.91% quarter-over-quarter from $858000.0 in Q4 2025.
C4 Therapeutics (CCCC) Accounts Payables (2019 - 2026) Analysis & Trends
C4 Therapeutics' Accounts Payables history runs 8 years deep, the most recent figure standing at $773000.0 for Q1 2026.
- In Q1 2026, Accounts Payables rose 13.18% year-over-year to $773000.0; the TTM figure through Mar 2026 stood at $773000.0 (up 13.18% YoY), while the FY2025 annual figure was $858000.0, down 35.39% from the prior year.
- Accounts Payables for Q1 2026 stood at $773000.0, down from $858000.0 in the prior quarter.
- The five-year high for Accounts Payables was $4.4 million in Q2 2022, with the low at $683000.0 in Q1 2025.
- The 5-year median for Accounts Payables is $1.3 million (2025), against an average of $1.7 million.
- The sharpest annual moves came in 2022 and 2025: Accounts Payables plunged 73.99% in 2022, then surged 142.72% in 2025.
- C4 Therapeutics' Accounts Payables stood at $1.2 million in 2022, then grew by 23.38% to $1.4 million in 2023, then fell by 8.16% to $1.3 million in 2024, then sank by 35.39% to $858000.0 in 2025, then decreased by 9.91% to $773000.0 in 2026.
- Business Quant data shows CCCC's Accounts Payables at $773000.0 in Q1 2026, $858000.0 in Q4 2025, and $1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | C4 Therapeutics | 521.12 Mn | 267.46 Mn | - | 1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Mn |
| Mar 31, 2026 | 773,000.00 |
| Dec 31, 2025 | 858,000.00 |
| Sep 30, 2025 | 1.33 Mn |
| Jun 30, 2025 | 2.22 Mn |
| Mar 31, 2025 | 683,000.00 |
| Dec 31, 2024 | 1.33 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 913,000.00 |
| Mar 31, 2024 | 1.63 Mn |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | 1.28 Mn |
| Jun 30, 2023 | 2.25 Mn |
| Mar 31, 2023 | 1.03 Mn |
| Dec 31, 2022 | 1.17 Mn |
| Sep 30, 2022 | 2.37 Mn |
| Jun 30, 2022 | 4.45 Mn |
| Mar 31, 2022 | 3.41 Mn |
| Dec 31, 2021 | 4.51 Mn |
| Sep 30, 2021 | 3.75 Mn |